Logo image of EQX.CA

EQUINOX GOLD CORP (EQX.CA) Stock Fundamental Analysis

TSX:EQX - Toronto Stock Exchange - CA29446Y5020 - Common Stock - Currency: CAD

8.67  -0.1 (-1.14%)

Fundamental Rating

5

Overall EQX gets a fundamental rating of 5 out of 10. We evaluated EQX against 802 industry peers in the Metals & Mining industry. EQX has an excellent profitability rating, but there are concerns on its financial health. EQX is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year EQX was profitable.
EQX had a positive operating cash flow in the past year.
Of the past 5 years EQX 4 years were profitable.
In the past 5 years EQX always reported a positive cash flow from operatings.
EQX.CA Yearly Net Income VS EBIT VS OCF VS FCFEQX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

EQX's Return On Assets of 5.05% is amongst the best of the industry. EQX outperforms 90.65% of its industry peers.
Looking at the Return On Equity, with a value of 9.99%, EQX belongs to the top of the industry, outperforming 92.87% of the companies in the same industry.
EQX has a better Return On Invested Capital (2.13%) than 89.42% of its industry peers.
EQX had an Average Return On Invested Capital over the past 3 years of 0.99%. This is significantly below the industry average of 24.51%.
The last Return On Invested Capital (2.13%) for EQX is above the 3 year average (0.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.05%
ROE 9.99%
ROIC 2.13%
ROA(3y)0.99%
ROA(5y)3.56%
ROE(3y)2.22%
ROE(5y)5.93%
ROIC(3y)0.99%
ROIC(5y)1.95%
EQX.CA Yearly ROA, ROE, ROICEQX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With an excellent Profit Margin value of 22.41%, EQX belongs to the best of the industry, outperforming 96.31% of the companies in the same industry.
In the last couple of years the Profit Margin of EQX has declined.
With an excellent Operating Margin value of 15.72%, EQX belongs to the best of the industry, outperforming 91.88% of the companies in the same industry.
In the last couple of years the Operating Margin of EQX has declined.
EQX has a Gross Margin of 34.64%. This is amongst the best in the industry. EQX outperforms 92.99% of its industry peers.
In the last couple of years the Gross Margin of EQX has declined.
Industry RankSector Rank
OM 15.72%
PM (TTM) 22.41%
GM 34.64%
OM growth 3Y1.42%
OM growth 5Y-4.29%
PM growth 3Y-24.11%
PM growth 5YN/A
GM growth 3Y-4.28%
GM growth 5Y-4.45%
EQX.CA Yearly Profit, Operating, Gross MarginsEQX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1

2. Health

2.1 Basic Checks

EQX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
EQX has more shares outstanding than it did 1 year ago.
EQX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EQX has a worse debt to assets ratio.
EQX.CA Yearly Shares OutstandingEQX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
EQX.CA Yearly Total Debt VS Total AssetsEQX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

EQX has an Altman-Z score of 1.02. This is a bad value and indicates that EQX is not financially healthy and even has some risk of bankruptcy.
EQX has a Altman-Z score (1.02) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.36 indicates that EQX is not too dependend on debt financing.
EQX has a worse Debt to Equity ratio (0.36) than 69.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.02
ROIC/WACC0.25
WACC8.65%
EQX.CA Yearly LT Debt VS Equity VS FCFEQX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

EQX has a Current Ratio of 1.14. This is a normal value and indicates that EQX is financially healthy and should not expect problems in meeting its short term obligations.
EQX has a Current ratio (1.14) which is comparable to the rest of the industry.
EQX has a Quick Ratio of 1.14. This is a bad value and indicates that EQX is not financially healthy enough and could expect problems in meeting its short term obligations.
EQX has a Quick ratio of 0.53. This is in the lower half of the industry: EQX underperforms 65.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.53
EQX.CA Yearly Current Assets VS Current LiabilitesEQX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 670.03% over the past year.
Measured over the past years, EQX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.64% on average per year.
The Revenue has grown by 39.14% in the past year. This is a very strong growth!
The Revenue has been growing by 39.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)670.03%
EPS 3Y-18.64%
EPS 5YN/A
EPS Q2Q%1600%
Revenue 1Y (TTM)39.14%
Revenue growth 3Y11.84%
Revenue growth 5Y39.98%
Sales Q2Q%93.08%

3.2 Future

Based on estimates for the next years, EQX will show a very strong growth in Earnings Per Share. The EPS will grow by 21.03% on average per year.
Based on estimates for the next years, EQX will show a small growth in Revenue. The Revenue will grow by 6.25% on average per year.
EPS Next Y341.1%
EPS Next 2Y152.51%
EPS Next 3Y82.44%
EPS Next 5Y21.03%
Revenue Next Year33.69%
Revenue Next 2Y23.64%
Revenue Next 3Y12.23%
Revenue Next 5Y6.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EQX.CA Yearly Revenue VS EstimatesEQX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
EQX.CA Yearly EPS VS EstimatesEQX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.90 indicates a quite expensive valuation of EQX.
Based on the Price/Earnings ratio, EQX is valued cheaper than 88.93% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.18. EQX is around the same levels.
Based on the Price/Forward Earnings ratio of 6.77, the valuation of EQX can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EQX indicates a rather cheap valuation: EQX is cheaper than 95.94% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of EQX to the average of the S&P500 Index (20.81), we can say EQX is valued rather cheaply.
Industry RankSector Rank
PE 29.9
Fwd PE 6.77
EQX.CA Price Earnings VS Forward Price EarningsEQX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EQX indicates a rather cheap valuation: EQX is cheaper than 92.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.59
EQX.CA Per share dataEQX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EQX may justify a higher PE ratio.
A more expensive valuation may be justified as EQX's earnings are expected to grow with 82.44% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y152.51%
EPS Next 3Y82.44%

0

5. Dividend

5.1 Amount

No dividends for EQX!.
Industry RankSector Rank
Dividend Yield N/A

EQUINOX GOLD CORP

TSX:EQX (5/2/2025, 7:00:00 PM)

8.67

-0.1 (-1.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners59.41%
Inst Owner ChangeN/A
Ins Owners5.43%
Ins Owner ChangeN/A
Market Cap3.95B
Analysts80
Price Target19.75 (127.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.78%
Min EPS beat(2)-24.27%
Max EPS beat(2)-21.28%
EPS beat(4)2
Avg EPS beat(4)8.29%
Min EPS beat(4)-24.27%
Max EPS beat(4)44.74%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.42%
Min Revenue beat(2)-3.12%
Max Revenue beat(2)0.27%
Revenue beat(4)1
Avg Revenue beat(4)-7.42%
Min Revenue beat(4)-13.9%
Max Revenue beat(4)0.27%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.71%
PT rev (3m)19.71%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-19.86%
EPS NY rev (1m)1.19%
EPS NY rev (3m)-14.59%
Revenue NQ rev (1m)-11.84%
Revenue NQ rev (3m)-25.28%
Revenue NY rev (1m)-6.51%
Revenue NY rev (3m)-13.89%
Valuation
Industry RankSector Rank
PE 29.9
Fwd PE 6.77
P/S 1.89
P/FCF N/A
P/OCF 7.69
P/B 0.84
P/tB 0.84
EV/EBITDA 8.59
EPS(TTM)0.29
EY3.34%
EPS(NY)1.28
Fwd EY14.76%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)1.13
OCFY13.01%
SpS4.59
BVpS10.29
TBVpS10.29
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.05%
ROE 9.99%
ROCE 3.95%
ROIC 2.13%
ROICexc 2.22%
ROICexgc 2.22%
OM 15.72%
PM (TTM) 22.41%
GM 34.64%
FCFM N/A
ROA(3y)0.99%
ROA(5y)3.56%
ROE(3y)2.22%
ROE(5y)5.93%
ROIC(3y)0.99%
ROIC(5y)1.95%
ROICexc(3y)1.04%
ROICexc(5y)2.21%
ROICexgc(3y)1.04%
ROICexgc(5y)2.21%
ROCE(3y)1.84%
ROCE(5y)3.63%
ROICexcg growth 3Y-8.65%
ROICexcg growth 5Y-13.76%
ROICexc growth 3Y-8.65%
ROICexc growth 5Y-13.76%
OM growth 3Y1.42%
OM growth 5Y-4.29%
PM growth 3Y-24.11%
PM growth 5YN/A
GM growth 3Y-4.28%
GM growth 5Y-4.45%
F-Score6
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 2.63
Cap/Depr 185.11%
Cap/Sales 27.22%
Interest Coverage 2.11
Cash Conversion 80.81%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.53
Altman-Z 1.02
F-Score6
WACC8.65%
ROIC/WACC0.25
Cap/Depr(3y)240.75%
Cap/Depr(5y)202.16%
Cap/Sales(3y)44.6%
Cap/Sales(5y)37.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)670.03%
EPS 3Y-18.64%
EPS 5YN/A
EPS Q2Q%1600%
EPS Next Y341.1%
EPS Next 2Y152.51%
EPS Next 3Y82.44%
EPS Next 5Y21.03%
Revenue 1Y (TTM)39.14%
Revenue growth 3Y11.84%
Revenue growth 5Y39.98%
Sales Q2Q%93.08%
Revenue Next Year33.69%
Revenue Next 2Y23.64%
Revenue Next 3Y12.23%
Revenue Next 5Y6.25%
EBIT growth 1Y379.57%
EBIT growth 3Y13.43%
EBIT growth 5Y33.98%
EBIT Next Year95.85%
EBIT Next 3Y36.75%
EBIT Next 5Y28.14%
FCF growth 1Y75.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.83%
OCF growth 3Y5.08%
OCF growth 5Y44.19%